Exemplis Discimus 2005, 149(1):43-50

Pellentesque erat libero, mattis ut, pellentesque sit amet, commodo et, sapien.

Mist Bokianaa, Betl Lopezb
a 1st Clinic of Nuclear Medicine, University Hospital of Felucia, Republic of Dagobah
b 2nd Clinic of Radiotherapy, Helo Prime] University Hospital, Republic of Geonosis

Cras enim felis, commodo sit amet, facilisis consequat, sodales a, diam. Mauris arcu est, facilisis non, consequat et, gravida sit amet, ligula. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Maecenas enim ligula, interdum ut, cursus id, lacinia in, eros. Phasellus ligula dolor, consectetuer viverra, accumsan vel, posuere et, lectus. Integer eros purus, sagittis nec, malesuada tincidunt, imperdiet nec, erat. Donec vehicula nisi ut pede ultrices suscipit.. Maecenas nulla lectus, tempor ac, tincidunt vel, mattis in, sem.

Kľúčové slová: Vivamus in nisl, Cras porttitor, Nam erat, Donec malesuada, Sed sit amet est, Phasellus commodo

Vložený: April 15, 2005; Přijatý: June 20, 2005; Uverejnené: July 1, 2005 

Zobraziť celý článok

Referencie

  1. Dean RT. (1975) Direct evidence of importance of lysosomes in degradation of intracellular proteins, Nature 257, 414-416. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  2. Conner GE. Cathepsin D. In : Barrett AJ, Rawlings ND, Woessner JF editors. Handbook of Proteolytic Enzymes, New York: Academic press 2002. 746-751.
  3. Schwann T. (1836) Über das wesen des Verdaungsprocesses. Arch. Anat. Phys. Wiss. Med. 90, 1976,
  4. Tang (1970) Gastricsin and pepsin Methods. Enzymol. 19, 406- 421. Prejsť k pôvodnému zdroju...
  5. Tang J, Wolf S, Caputto R, Trucco R.E. (1959) Isolation and crystallization of gastricsin from human gastric juice. J. Biol. Chem. 234, 1174-1178. Prejsť na PubMed...
  6. Nishimura H. Comparative endocrinology of renin and angiotensin. In: Alan J, Anderson RR, editors. The Renin Angiotensin System. New York, Plenum Publishing , 1980. p. 29-77. Prejsť k pôvodnému zdroju...
  7. Jupp RA, Richards AD, Kay J, Dunn BM, Wyckoff J.B., Samloff IM, Yamamoto K. (1988) Identification of aspartic proteinases from human erythrocyte membranes and gastric mucosa (slow moving proteinase) as catalytically equivalent to cathepsin E. Biochem J. 254, 895-898. Prejsť na PubMed...
  8. Hong L, Koelsch G, Lin XL, Wu SL, Terzyan S, Ghosh AK, Zhang XC, Tang J. (2000) Structure of the protease domain of memapsin 2 ( secretase) complexed with inhibitor. Science 290, 150-153. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  9. Fusek M, Vetvicka V. Cathepsin D. In : Fusek M, Vetvicka V. editors. Aspartic Proteinases: Physiology and Pathology. Boca Ratton: CRC Press, 1995. p. 143-184.
  10. Hackenthal E, Paul M, Ganten D, Taugner R. (1990) Morphology, physiology, and molecular biology of renin secretion. Physiol.Rev. 70, 1067-1116. Prejsť na PubMed...
  11. Tang J, James MNG, Hsu I, Jenkins JA, Blundell TL. (1978) Structural evidence for gene duplication in the evolution of the acid proteases. Nature 271, 618-621. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  12. James MNG, Sielecki AR. (1986) Molecular structure of an aspartic proteinase zymogen, porcine pepsinogen, at 1.8 resolution. Nature 319, 33-38 Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  13. Hartsuck JA, Koelsch G, Remington SJ. (1992) The high-resolution crystal structure of porcine pepsinogen. Proteins: Structure, Function, Genetics 13, 1-25.
  14. Andreeva NS, Zdanov AS, Gustchina AE, Fedorov AA. (1984) Structure of ethanol inhibited porcine pepsin at 2 resolution and binding of the methylester of phenylalanyl-diodotyrosine to the enzyme. J.Biol.Chem. 259, 11353-11365.
  15. Cooper JB, Khan G, Taylor G, Tickle IJ, Blundell TL. (1990) X-ray analyses of aspartic proteinases. II Three dimensional structure of the hexagonal crystal form of porcine pepsin at 2.3 resolution. J.Mol.Biol. 214, 199-222. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  16. Metcalf P, Fusek M. (1993) Two crystal structures for cathepsin D: The lysosomal targeting signal and active site. EMBO J. 12, 1293-1302. Prejsť na PubMed...
  17. Baldwin ET, Bhat TN, Gulnik S, Hosur MV, Sowder RC, Cachau RE, Collins J, Silva AM, Erickson JW. (1993) Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc. Natl. Acad. Sci. USA 90, 6796-6800. Prejsť k pôvodnému zdroju...
  18. Sielecki AR, Hayakawa K, Fujinaga M, Murphy MEP, Fraser M, Muir AK, Carllil CT, Lewicki JA, Baxter JD, James MNG. (1989) Structure of recombinant human rennin, a target for cardiovascularactive drugs, at 2.5 resolution. Science 243, 1346-1351. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  19. Rahuel J, Priestle JP, Grutter MG. (1991) The crystal structures of recombinant glycosylated human rennin alone and on complex with transition state analog inhibitor. J.Structural Biol. 107, 227-36. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  20. Kageyama T, Ichinose M, Miki K, Athauda SB, Tanji M, Takahashi K. (1989) Difference of activation processes and structure of activation peptides in human pepsinogens A and progastricsin. J.Biochem. 105, 15-22. Prejsť na PubMed...
  21. Conner GE, Richo G. Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D. (1992) Biochemistry 31, 1142-1147.
  22. Schechter I, Berger A. (1967) On the size of the active site in proteases. I. Papain. Biochem, Biophys, Res. Commun. 27, 157-162. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  23. Horishima H, Takita T, Aoyagi T, Takeuchi T, Umezawa H. (1970) The structure of pepstatine, J. Antibiot. 23, 263-271. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  24. Abdel-Meguid SS. (1993) Inhibition of aspartyl proteinases. Med. Res.Rev. 13, 731-778. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  25. Dahms NM, Lobel P, Kornfeld S. (1989) Mannose-6-phosphate receptors and lysosomal enzyme targeting. J.Biol.Chem. 264, 12115-12118.
  26. von Figura K, Hasilik A (1986) Lysosomal enzymes and their receptors. Annu. Rev. Biochem. 55, 167-193. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  27. Dittmer F, Ulbrich EJ, Hafner A, Schmahl W, Meister T, Pohlmann R, von Figura K. (1999) Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific. J Cell Sci 112, 1591-1597. Prejsť na PubMed...
  28. Zhu Y, Conner GE. (1994) Intermolecular association of lysosomal protein precursors during biosynthesis. J. Biol. Chem. 269, 3846-3851. Prejsť na PubMed...
  29. Gopalakrishnan MM, Grosch H-W, Locatelli-Hoops S, Werth N, Smolenová E, Nettersheim M, Sandhoff K, Hasilik A. (2004) Purified recombinant human prosaponin forms oligomers that bind procathepsin D and affect its autoactivation, Biochem J. 383, 507-15. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  30. Koelsch G, Mares M, Metcalf P, Fusek M. (1994) Multiple functions of pro-parts of aspartic proteinase zymogens. FEBS Lett. 343, 6-10. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  31. Fusek M, Baudys M, Metcalf P(1992) Purification and crystallization of human cathepsin D. J. Mol. Biol. 226, 555-557. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  32. Mohamadzadeh M, Mohamadzadeh H, Brammer M, Sestak K, Luftig RB. (2004) Identification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD). J. Immune Based Ther. Vaccines 2, 8-10. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  33. Vetvicka V, Vagner J, Baudys M, Tang J, Foundling SI, Fusek M. (1993) Human breast milk contains procathepsin D-detection by specific antibodies. Biochem. Mol. Biol. Int. 30, 921-928. Prejsť na PubMed...
  34. Safting P, Hetman M, Schmahl W. (1995) Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 14, 3599-3608. Prejsť na PubMed...
  35. Bidere N, Lorenzo HK, Carmona S, Laforge M, Harper F, Dumont C, Senik A. (2003) Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 278, 31401-31411. Prejsť k pôvodnému zdroju...
  36. Shibata M, Kanamori S, Isahara K, OhsawaY, Konishi A, Kametaka S, Watanabe T, Ebisu S, Ishido K, Kominami E, UchiyamaY. (1998) Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem. Biophys. Res. Comm. 51, 199-203. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  37. Takuma K, Kiriu M, Mori K, Lee E, Enomoto R, Baba A, Matsuda T. (2003) Roles of cathepsins in reperfusion-induced apoptosis in cultured astrocytes. Neurochem. Int., 42 153-9. Prejsť k pôvodnému zdroju...
  38. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. (1996) Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J., 15, 3861-70. Prejsť na PubMed...
  39. McIntyre GF, Erickson AH. (1991) Procathepsins L and D are membrane-bound in acidic microsomal vesicles. J.Biol.Chem. 266, 15438-15445.
  40. Diment S, Leech MS, Stahl PD (1998) Cathepsin D is membraneassociated in macrophage endosomes J.Biol.Chem. 263, 6901- 6907.
  41. Rochefort H, Capony F, Garcia M, Cavailles V, Freiss G, Chambon M, Morisset M, Vignon F. (1987) Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J. Cell. Biochem. 35. 17-29.
  42. Rochefort H, Garcia M, Glondu M, Laurent V, Liaudet E, Rey J, Roger P. (2000) Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. Clin. Chim. Acta. 291, 157-170. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  43. Vetvicka V, Benes P, Fusek M. (2002) Procathepsin D in breast cancer: What do we know? Effects of ribozymes and other inhibitors. Cancer Gene Ther. 9, 854-863. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  44. Cavailles V, Augereau P, Rochefort H. (1993) Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells., Proc. Natl. Acad. Sci. U S A. 90, 203-7. Prejsť k pôvodnému zdroju...
  45. Vignon F, Capony F, Chambon M, Freiss G, Garcia M, Rochefort H. (1986) Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52K protein. Endocrinology 118, 1537-1545 Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  46. Vetvicka V, Vetvickova J, Fusek M (1994) Effect of human procathepsin D on proliferation of human cell lines. Cancer Lett. 79, 131-135. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  47. Rochefort H. (1992) Biological and clinical significance of cathepsin D in breast cancer. Acta Oncol. 31, 125-130. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  48. Rochefort H. (1992) Cathepsin D in breast cancer: A tissue marker associated with metastasis. Eur. J. Cancer 28A, 1780-1783. Prejsť k pôvodnému zdroju...
  49. Leto G, Gebbia N, Rausa L, Tumminello FM. (1992) Cathepsin D in the malignant progression of neoplastic diseases, Anticancer Res. 12, 235-240. Prejsť na PubMed...
  50. Leto G, Tumminello FM, Crescimanno M, Flandina C, Gebbia N. (2004) Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin. Exp. Metastases 21, 91-106. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  51. Brouillet JP, Dufour F, Lemamy G, Garcia M, Schlup N, Grenier J, Mani JC, Rochefort H. (1997) Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro- cathepsin D immunoassay. Cancer 79, 2132-2136. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  52. Ferrandina G, Scambia G, Bardelli F, Panici PB, Mancuso S, Messori A. (1997) Relationship between cathepsin-D content and disease free survival in node-negative breast cancer patients: A meta-analysis. Br. J. Cancer 76, 661-666. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  53. Foekens JA, Look MP, Bolt-de Vries J, Meijer-van Gelder ME, van Putten WL, Klijn JG. (1999) Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br. J. Cancer 79, 300-307. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  54. Roger S, Day CA, Fox SB. (1993) Expression of cathepsin D and estrogen receptors in male breast carcinoma. Human Pathol. 24, 148-151. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  55. Meijer-van Gelder ME, Look MP, Bolt-de Vries J, Peters HA, Klijn JG, Foekens JA. (2001) Clinical relevance of biological factors in male breast cancer. Breast Cancer Res. Treat 68, 249-60. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  56. Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E. Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 21, 5951-5955.
  57. Vetvicka V, Vetvickova J, Hilgert I, Voburka Z, Fusek M. (1997) Analysis of the interaction of procathepsin D activation peptide with breast cancer cells. Int J Cancer. 73, 403-9. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  58. Vetvicka V, Vetvickova J, Benes P. (2004) Role of enzymatically inactive procathepsin D in lung cancer. Anticancer Res. 24, 2739- 2743. Prejsť na PubMed...
  59. Fusek M, Vetvicka V. (1994) Mitogenic function of human procathepsin D-role of the activation peptide. Biochem J 303, 775- 780. Prejsť na PubMed...
  60. Glondu M, Coopman P, Laurent-Matha V, Garcia M, Rochefort H, Liaudet-Coopman E (2001) A mutated cathepsin D devoid of its catalytic activity stimulates the growth of cancer cells. Oncogene 20, 6920-6929. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  61. Laurent-Matha V, Maruani-Herrman S, Prebois C, Beaujoin M, Glondu M, Noel A, Alvarez-Gonzales ML, Blacher S, Coopman P, Baghdiguian S, Gilles C, Lancarek J, Freiss G, Vignon F, Liaudet- Coopman E. (2005) Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J. Cell Biol. 168, 489-499. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  62. Vetvicka V, Vetvickova J, Fusek M. (1999) Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development. Breast. Cancer. Res. Treat. 57, 261-269. Prejsť k pôvodnému zdroju... Prejsť na PubMed...

Späť na obsah